Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05207865
Study type Interventional
Source Biohaven Pharmaceuticals, Inc.
Contact Elyse Stock, MD
Phone 203-404-0410
Email [email protected]
Status Recruiting
Phase Phase 4
Start date March 15, 2022
Completion date September 20, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03832998 - Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Phase 3
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Vestibular Neurectomy N/A
Completed NCT04179474 - Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine Phase 1
Recruiting NCT04603976 - Registry for Migraine - Clinical Core Phase 4
Completed NCT03597529 - CHOCOlate MeLatonin for AdolescenT MigrainE Phase 2
Completed NCT04197349 - Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman Phase 1
Enrolling by invitation NCT05064371 - Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan Phase 3
Not yet recruiting NCT04069572 - Vibratory Stimulation for the Treatment of Chronic Pain N/A
Not yet recruiting NCT04859374 - Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach N/A
Not yet recruiting NCT04925414 - Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx) Phase 4
Not yet recruiting NCT03083860 - Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions. N/A
Completed NCT02905227 - A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder Phase 1
Enrolling by invitation NCT02532023 - The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients Phase 4
Completed NCT02108678 - One-Day Intervention for Depression and Impairment in Migraine Patients N/A
Completed NCT01741246 - Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging N/A
Completed NCT01225263 - Statin/Vitamin D & Migraine Study Phase 2
Completed NCT01138150 - Ictal and Interictal Inflammatory Markers in Migraine Phase 4
Completed NCT01080287 - The Identification and Characterization of Autonomic Dysfunction in Migraineurs With and Without Auras N/A
Not yet recruiting NCT00969995 - Identification of Inflammatory Markers in Migraine Patients N/A
Completed NCT01161667 - Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions N/A